Understanding the differences between available medications, their mechanisms of action, and individual tolerance factors helps patients and healthcare providers select the most appropriate treatment
William Nichols Industry news Industry news Category news Category news Reports Key trends Multimedia Journal Events Suppliers Home Industry news Industry news Category news Category news Reports Key trends Multimedia Events Suppliers Innovation at the sweet spot: GLP-1, allulose and the rise of post-sweeteners William Nichols Key takeaways Consumers prioritize ingredient transparency and clean labeling over just sugar reduction, with allulose being a popular alternative
Common Side Effects During Your First Week on GLP-1 During the first week of GLP-1 therapy, most patients experience some degree of gastrointestinal side effects , which are the most frequently reported adverse reactions with this medication class
Considering the lack of robust cellular models for endogenous human GLP-1R, we developed a cell line with a GLP-1R density more comparable with endogenous tissue levels ( 30 )
Ciprofloxacin, a second-generation fluoroquinolone antibiotic, is considered the most effective quinolone 22